by healthadvances Posted on March 14, 2018March 14, 2018 Seattle’s Journey to the Summit of Cancer Commercialization Read More
by healthadvances Posted on March 13, 2018 The Accelerated Access Review in the UK: Quicker Access to Innovative Drugs and Diagnostics, Medical and Digital Technologies Read More
by healthadvances Posted on February 16, 2018March 22, 2018 Why Flatiron’s Big Exit May Not Be the Boon for Digital Health That Some Expect Read More
by healthadvances Posted on January 19, 2018 PART 3: What’s Next in 2018? Advanced Therapeutics – Gene Therapy, CAR-T, and Microbiome Read More
by healthadvances Posted on January 16, 2018January 16, 2018 PART 2: 2018 Wildcards – Healthcare Regulation and Models of Care Read More
by healthadvances Posted on January 12, 2018January 12, 2018 PART 1: Reflections on 2017 – Biopharma Therapeutics Read More
by healthadvances Posted on November 13, 2017November 15, 2017 Who’s Really First in FDA Cleared Digital Therapeutics? Read More
